For patients with advanced esophageal cancer, the choice of treatment often feels like a gamble. A new analysis of 3,721 patients offers clearer hope. Those who received conversion surgery after initial therapy lived significantly longer than those who got definitive therapy alone. This approach boosted one-year survival from 49.6 percent to 73.6 percent. At three years, survival rose from 18.4 percent to 37.0 percent. By five years, the difference grew even wider, reaching 26.5 percent versus 11.6 percent. The benefit was especially strong for a specific subgroup with the most advanced disease, where one-year survival jumped from 37.6 percent to 86.4 percent. This analysis looked at data from many different sources to find these patterns. The results suggest that adding surgery to the treatment plan can make a real difference in how long people live. However, the researchers noted that the results for the most advanced disease group need more proof from larger studies. Until then, this data gives a strong signal that surgery may be the better path for many patients facing this difficult diagnosis.
Conversion surgery after induction therapy improves 5-year survival to 26.5% versus 11.6% in cT4 esophageal cancer patientsConversion surgery after induction therapy improves survival for advanced esophageal cancer patients
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Note that conversion surgery improves 5-year survival to 26.5% versus 11.6% in cT4 esophageal cancer.
This systematic review and meta-analysis assesses the impact of conversion surgery following induction therapy compared to definitive therapy in patients with cT4 esophageal cancer. The analysis included a total sample size of 3721 patients across the included studies. The primary outcome measured was overall survival at one, three, and five years.
Results indicate significantly better survival for the conversion surgery group. At one year, overall survival was 73.6% versus 49.6% for definitive therapy. At three years, survival was 37.0% versus 18.4%. At five years, survival was 26.5% versus 11.6%. In the cT4b subgroup, one-year survival was 86.4% versus 37.6%, and three-year survival was 48.6% versus 11.4%.
The authors highlight that the survival benefit of conversion surgery for cT4b disease requires further validation in larger prospective studies. Safety data and adverse events were not reported in this review. The certainty of the evidence was not reported. Clinicians should interpret these findings with caution regarding the cT4b subgroup until prospective data are available.
What this means for you:
Conversion surgery after induction therapy significantly improves survival for patients with advanced esophageal cancer. More on Cancer
Age and comorbidity do not raise severe complication risk after minimally invasive esophagectomy
Older esophageal cancer patients face no higher risk of severe complications with minimally invasive surgery
A secondary analysis of an RCT found that older age and higher comorbidity were not linked to more severe complications after minimally inva…
Analysis of 245 patients shows age and health conditions do not increase severe complication rates after minimally invasive esophagectomy.
Prolonged time-to-surgery after chemoradiotherapy improves preoperative quality of life in esophageal cancer
Waiting Longer for Esophageal Cancer Surgery Backfires Despite Feeling Better
This randomized controlled trial in patients with locally advanced resectable esophageal cancer compared prolonged (10-12 weeks) versus stan…
• Longer wait worsens cancer outcomes despite better pre-op quality of life • Helps patients facing surgery after chemoradiotherapy • Standa…
Structured perioperative rehabilitation reduces postoperative pneumonia in esophageal cancer patients
Lung Problems After Esophagus Surgery Drop Sharply With This Approach
This systematic review and meta-analysis evaluated 37 studies involving postoperative patients with esophageal cancer receiving structured p…
Starting rehab before esophageal cancer surgery and continuing it afterward may sharply lower the risk of dangerous lung infections.
cGAS-STING signaling pathway activation drives inflammation, fibrosis, and functional decline in various kidney diseases
Immune pathway linked to kidney disease progression
This systematic review explores the role of the cGAS-STING signaling pathway in renal pathologies. The authors conclude that this pathway is…
A newly mapped immune pathway may drive kidney damage, opening doors for future treatments.
View Original Abstract ↓
BACKGROUND: cT4 esophageal cancer represents a major therapeutic challenge, with definitive chemoradiotherapy (dCRT) currently considered the standard treatment. However, survival outcomes remain unsatisfactory. CS following induction therapy has emerged as a potential alternative strategy, though its clinical effectiveness remains under debate. This systematic review and meta-analysis aimed to compare survival outcomes between conversion surgery (CS) and definitive therapy in patients with cT4 esophageal cancer.
METHODS: Relevant literature was retrieved from PubMed, the Cochrane Library, and Embase. Patients were categorized into the CS group or the definitive therapy group. A systematic review and meta-analysis were performed to evaluate 1-, 3-, and 5-year overall survival (OS) outcomes in patients with esophageal cancer. Odds ratios, mean differences, and 95% confidence intervals were calculated using fixed-effects or random-effects models.
RESULTS: Seventeen studies involving a total of 3721 patients with cT4 esophageal cancer were included. After excluding studies with high heterogeneity, CS was associated with significantly better survival compared to definitive therapy at 1-year (73.6% vs. 49.6%), 3-year (37.0% vs. 18.4%), and 5-year (26.5% vs. 11.6%) OS. A subgroup analysis of three studies including 341 patients with cT4b disease revealed a significant survival advantage for the CS group in both 1-year OS (86.4% vs. 37.6%) and 3-year OS (48.6% vs. 11.4%).
CONCLUSIONS: CS following induction therapy significantly improves survival in patients with cT4 esophageal cancer. However, the survival benefit of CS for cT4b disease requires further validation in larger prospective studies.
Global GJB2 mutation prevalence in nonsyndromic hearing impairment
One in four people with hearing loss carries a specific gene mutation
Related in ENT (Otolaryngology)
Exercise combined with CBT is the most consistently supported intervention for improving insomnia sleep quality
Exercise combined with therapy shows promise for treating insomnia
This systematic review and network meta-analysis of 31 RCTs involving 2,457 participants found that exercise combined with cognitive behavio…
Combining exercise with cognitive behavioral therapy may improve sleep quality and help people fall asleep faster when dealing with chronic …
Children with hearing loss demonstrate significantly lower physical fitness in strength, agility, speed, and balance
Children with Hearing Loss Show Lower Physical Fitness Levels
This meta-analysis of 5 observational studies involving 404 children and adolescents found significant differences in physical fitness compa…
Children and adolescents with hearing loss may have lower strength, agility, speed, and balance compared to their peers without hearing loss…
Review compares LLM and physician responses to otologic questions on Reddit
AI Answers Ear Questions With More Empathy Than Doctors
This review analyzed 49 otology-related questions from Reddit's r/AskDocs, comparing responses from ChatGPT-4o, ClaudeAI, and Google Gemini …
AI tools might offer clearer, kinder answers to common ear problems than busy doctors.
Neurotological evaluation distinguishes vestibular migraine from viral neuritis in acute unilateral vestibulopathy
A single case report shows rapid recovery in vestibular migraine
This case report describes a 40-year-old woman with a history of migraine with aura presenting to the emergency department with vestibular m…
A 40-year-old woman with vestibular migraine recovered her balance quickly. This case suggests that specific reflex patterns help doctors te…
From Other Specialties
Early childhood caries affects 17% to 57% of children in Africa, umbrella review finds
Factors Influencing Early Childhood Caries in Children Across Africa
This umbrella review of systematic reviews found that early childhood caries (ECC) prevalence in African children ranges from 17% to 57%, wi…
New data highlights how diet, oral hygiene, and feeding habits contribute to the high rates of early childhood tooth decay in children acros…
ADOS-2 shows 0.88 sensitivity and 0.74 specificity for diagnosing autism spectrum disorder
New analysis shows how well the ADOS tool identifies autism
This systematic review and meta-analysis of 10 studies evaluates the diagnostic accuracy of the ADOS-2 in real-world clinical settings. The …
A new review finds that the ADOS-2 tool is highly effective at identifying autism, especially in toddlers.
Sex-specific genetic risk loci and causal proteins in Parkinson's disease
Identifying Sex Specific Genetic Risks and Brain Proteins in Parkinson Disease
A meta-analysis identifies 10 candidate proteins with sex-biased causal links to Parkinson's disease, highlighting GALC and PSMG1 in females…
New research reveals how sex differences influence genetic risks and protein levels in Parkinson's disease to help tailor future treatments.
Amblyopia impacts reading speed, eye movements, and crowding in patients with binocular vision disorders
Amblyopia slows reading speed and eye movements
This narrative review examines the impact of amblyopia and reduced viewing conditions on reading ability. The authors conclude that amblyopi…
Amblyopia can slow reading and disrupt eye movements, but no treatments target these reading problems yet.